Tag Archives: OSE Immunotherapeutics

Boehringer Ingelheim and OSE Immunotherapeutics Forge New Paths in Disease Treatment Collaboration

(IN BRIEF) Boehringer Ingelheim and OSE Immunotherapeutics announce a significant expansion of their partnership, introducing two novel projects to develop pioneering treatments alongside their ongoing anti-SIRPα immuno-oncology initiatives. The expansion includes broadening therapeutic evaluations to encompass cardiovascular-renal-metabolic (CRM) diseases and … Read the full press release